Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Obesity is a growing concern worldwide, including in low- and middle-income countries (LMICs). Addressing this issue involves various strategies, including dietary and lifestyle changes, medical ...

A MUM who once despised herself because of her weight has revealed how she lost over 100lbs and transformed her life to become a beauty queen. Carlene Booth, from Cumbernauld, battled a binge ...

Braga Fresh, based in California, issued a product warning for Marketside Broccoli Florets, the FDA announced last year. It's ...